OVOL2 and breast cancer: We previously found that mRNA levels of OVOL2 decreased at a late stage of human breast cancer progression.[20] To further elucidate the impact of OVOL2 on breast cancer carcinogenicity, we analyzed OVOL2 expression across different molecular subtypes using data from UALCAN and Oncomine databases.